A November we’ll remember Well folks, November is upon us. October was an important month for us, even though it may not seem so at first glance.The timing of the markets worked in our favour; management worked behind the scenes on the Penta5 acquisition, and investors large and small were given ample time to quietly accumulate. As we enter the first full week of November, what do we see? Broad markets are recovering from healthy corrections, Short data from Nov 1st shows 21% of total volume traded of PREV, is short; up from 17% on October 16th. Preveceutical Medical is becoming increasingly popular. Even Hedge funds are aware of it, although from what I hear, they haven’t quite taken interest... yet. Folks, I am going to call this right now: we are in the makings of a perfect storm. When the timing is right, Mr. Stephen Van Deventer, the man who, along with his wife, brought our second largest Canadian LP to market, will break news on what I believe to be a pivotal deal in the future of this very young and bright company. Those that have been in line for sometime will be handsomely rewarded. A November we’ll remember.